(P83.2) Hydrops fetalis not due to haemolytic disease

More details coming soon

Icon
816 448 in individuals diagnosis hydrops fetalis not due to haemolytic disease confirmed
Icon
5 201 deaths with diagnosis hydrops fetalis not due to haemolytic disease
Icon
1% mortality rate associated with the disease hydrops fetalis not due to haemolytic disease

Diagnosis hydrops fetalis not due to haemolytic disease is diagnosed Men are 21.69% more likely than Women

496 776

Men receive the diagnosis hydrops fetalis not due to haemolytic disease

2 836 (0.6 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
319 672

Women receive the diagnosis hydrops fetalis not due to haemolytic disease

2 365 (0.7 %)

Died from this diagnosis.

Risk Group for the Disease hydrops fetalis not due to haemolytic disease - Men and Women aged 0

Icon
In Men diagnosis is most often set at age 0-19
Icon
Less common in men the disease occurs at Age 20-95+Less common in women the disease occurs at Age 5-14, 25-29, 35-95+
Icon
In Women diagnosis is most often set at age 0-5, 15-24, 30-34

Disease Features hydrops fetalis not due to haemolytic disease

Icon
Absence or low individual and public risk
Icon

Hydrops fetalis not due to haemolytic disease - what does this mean

Hydrops fetalis not due to haemolytic disease occurs when a fetus has an accumulation of fluid in two or more body cavities, such as the abdomen, chest, and/or skin, due to a variety of causes such as congenital heart defects, infections, and chromosomal abnormalities. it is diagnosed by ultrasound and can be managed with medications, surgery, or other treatments depending on the underlying cause.

What happens during the disease - hydrops fetalis not due to haemolytic disease

Hydrops fetalis not due to haemolytic disease is a condition characterized by an excessive amount of fluid in the body cavities of a fetus or newborn. it is caused by an imbalance between the production and absorption of fluid in the body which can be caused by a variety of factors including genetic disorders, infections, and structural defects in the heart or lungs. in some cases, hydrops fetalis can be caused by an abnormal response of the fetal immune system to certain substances in the mother's blood. these substances can cause inflammation in the fetus, leading to fluid accumulation and the development of hydrops fetalis.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Obtain medical history of mother and fetus
  • Perform physical examination of the fetus
  • Order laboratory tests, such as amniocentesis, to identify the cause of hydrops fetalis
  • Perform imaging tests, such as ultrasound or magnetic resonance imaging (MRI), to evaluate the fetus and identify any structural abnormalities
  • Perform genetic testing to identify any genetic abnormalities associated with hydrops fetalis
  • Perform chromosomal analysis to identify any chromosomal abnormalities associated with hydrops fetalis
  • Order additional tests, such as fetal echocardiography or fetal MRI, to evaluate the cardiovascular system
  • Perform fetal blood sampling to evaluate the fetus’s red blood cell count and hemoglobin levels

Treatment and Medical Assistance

Main goal of the treatment: Improve the outcome of the fetus.
  • Monitoring of amniotic fluid volume
  • Monitoring of fetal heart rate
  • Monitoring of maternal serum alpha-fetoprotein levels
  • Ultrasound imaging to evaluate fetal anatomy
  • Amniocentesis to evaluate fetal lung maturity
  • Cordocentesis to evaluate fetal hematological parameters
  • Treatment of maternal infection
  • Fetal blood transfusion
  • Fetal surgery
  • Delivery of the fetus
Icon
8 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Hydrops fetalis not due to haemolytic disease - Prevention

Hydrops fetalis not due to haemolytic disease can be prevented by avoiding or managing underlying conditions such as infections, congenital abnormalities, and maternal metabolic disorders. additionally, prenatal screening and genetic counseling should be offered to pregnant women to identify and manage any potential risk factors.